Hunterdon Hematology Oncology is committed to bringing you new and innovative investigational cancer treatment options. One way we do this is by participating in cancer research trials and studies. A clinical trial is a controlled study in which patients participate in the assessment of a new treatment for a specific cancer. The trial treatment may involve a new way of combining existing treatment drugs, or the use of a newly developed drug. The trial will prove the effectiveness of the new treatment compared to existing treatments, as well as determine possible side-effects and ways to manage them. Benefits of a clinical trial include access to the most up-to-date research and drugs, particularly if the existing approved drug treatments are not proving to be effective for your type of cancer. Hunterdon Hematology Oncology’s association with Fox Chase Cancer Center enables us to participate in many of their clinical trials so that you may receive the clinical trial treatment without having to travel to Fox Chase. If it is warranted for your type and stage of cancer, and you wish to participate in a clinical trial that is not offered at our facility, your doctor can assist you in finding a clinical trial at another facility and make the appropriate referrals.
We currently have clinical trials for patients with the following conditions (please click one to learn more):
- Oral Mucositis in Newly Diagnosed Head and Neck Cancers
- MATCH: Genetic Testing on Most Cancer Types
- Multiple Myeloma
- Polycythemia Vera
- Essential Thrombocythemia
To learn more about a specific clinical trial, please contact our Clinical Trial Coordinator by dialing 908.237.2330 extension 2.